Invesaro

Stocks CVCO Financial statements

Financial statements

CAVCO INDUSTRIES, INC. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data CAVCO INDUSTRIES, INC. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue7748719631,0621,1081,6272,1431,7952,0152,245
Cost of revenue6166917578318691,2181,5881,3681,5501,718
Gross profit158181206231239409555427466527
Selling, general and administrative101107122146150206258248275298
Operating income56.873.884.184.988.8202297179190229
Interest expense4.444.43.441.50.740.70.911.650.520.54
Interest income2.143.5410.72121.116.3
Other non-operating income0.390.850.220.34
Pre-tax income55.378.586.79396.9212307199211245
Income tax17.31718.117.920.314.265.941.34054.1
Net income to minority interests000.040.290.09
Net income3861.568.675.176.6198241158171191
EBITDA60.577.888.890.795.1214314198210252
EPS, basic4.236.827.568.228.3421.5427.2018.5520.9724.26
EPS, diluted4.176.687.408.108.2521.3426.9518.3720.7123.98
Shares, basic (weighted)8.989.029.089.139.199.188.848.518.167.85
Shares, diluted (weighted)9.119.29.279.279.299.268.928.598.267.95

Balance sheet

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash and equivalents133187187242322244271353356237
Short-term investments11.311.912.614.619.520.11518.319.816.2
Receivables29.43540.742.847.496.189.377.1106108
Inventory93.9109116114131244263241253296
Other current assets29.82844.742.257.871.792.982.974.871.6
Total current assets357419462516652744805852910825
Property, plant and equipment5763.463.577.296.8164228224228279
Lease right-of-use assets013.916.31726.83935.633.6
Goodwill72.975.175.1101115122122209
Intangible assets9.7815.114.428.529.828.216.728.1
Long-term investments30.333.632.131.63534.918.617.318.138.2
Total assets6076757258109521,1551,3081,3541,4071,491
Accounts payable2423.829.329.932.143.130.733.537.244.2
Accrued liabilities110127125140203251263240266291
Deferred revenue17.822.141.856.345.240.946.954.1
Total current liabilities140176174172237294293273303335
Lease liabilities010.713.413.221.735.131.530.7
Other non-current liabilities10.87.827.767.367.1
Total liabilities213218196203268324330321342388
Total debt5859.834.11512.211.610.98.087.687.43
Paid-in capital245246249252254263272281291300
Retained earnings1482092803554316298691,0271,1981,389
Treasury stock0-1.44-61-164-275-425-586
Other comprehensive income1.41.4-0.030.090.1-0.4-0.62-0.330.010.03
Shareholders' equity3944575306086848309761,0331,0651,103
Minority interests0000.831.220
Total equity3944575306086848319781,0331,0651,103
Total liabilities and equity6076757258109521,1551,3081,3541,4071,491
Shares outstanding8.999.049.19.178.678.328.017.74

Cash flow statement

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Net income3861.568.675.176.6198241158171191
Depreciation and amortization3.694.034.75.786.321116.918.519.323
Stock-based compensation2.132.323.373.884.395.066.266.768.6812.8
Deferred income tax0.27-4.31-0.240.20.32-1.791.97-3.06-6.529.72
Change in receivables-0.37-4.12-5.68-1.44-4.6-27.310.211.6-28.82.89
Change in inventory0.96-13.4-7.058.25-17.7-73.838.944.9-11.44.88
Change in payables17.47.324.716.4447.238.2-13.4-22.329.413.8
Cash from operations45.85932.8102114144256225178267
Capital expenditures-5.3-8.39-7.64-14.3-25.5-18.7-44.1-17.4-21.4-35.4
Acquisitions0-1.640-15.90-141-106-19.20-173
Purchases of investments-11.7-17.5-12.8-12.5-13-28.1-34.5
Sales and maturities of investments10.219.512.518.913.125.420.1
Cash from investing-7.06-4.67-5.82-25.2-23.3-159-129-31.7-24-222
Stock issued-1.39-0.92-0.11-1.072.684.423.714.54.482.23
Share buybacks00-1.44-59.6-103-109-149-160
Cash from financing-2.960.12-26.4-20.8-6.98-65.1-102-108-148-163
Net change in cash35.854.40.6155.783.7-8024.285.36.59-118
Free cash flow40.550.625.287.488.5126212207157232
Interest paid3.42.912.30.740.470.450.620.80.010.27
Income taxes paid18.117.319.918.819.531.482.436.845.639.3

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 27, 2026; growth uses fiscal years. Valuation uses the share price of $557.28 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin23.2%Gross profit / revenue.
Operating margin9.6%Operating income / revenue.
EBITDA margin10.6%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin10.2%Pre-tax income / revenue.
Net margin7.9%Net income / revenue.
FCF margin10.2%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin12.5%Cash from operations / revenue.
Effective tax rate23.0%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)16.3%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)11.8%Net income / average total assets.
Return on invested capital (ROIC)19.6%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue13.5%Selling, general and administrative expense / revenue.
Stock-based pay / revenue0.6%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue2.3%Capital expenditures / revenue.
D&A / revenue1.0%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y11.4%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y1.6%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y15.2%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y13.2%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y-1.7%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y17.1%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y20.1%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y-8.3%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y20.8%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y20.1%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y-7.1%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y21.5%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y11.4%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y-7.5%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y20.0%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y15.8%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y-3.8%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y23.8%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y49.9%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y1.5%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y18.6%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y47.8%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y3.1%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y21.3%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y3.6%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y4.2%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y10.0%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y6.0%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y4.5%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y9.4%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-3.8%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-3.8%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-3.1%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio2.23xCurrent assets / current liabilities.
Quick ratio1.00x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.70x(Cash + short-term investments) / current liabilities.
Liabilities / assets28.0%Total liabilities / total assets.
Interest coverage434xOperating income / interest expense.
Working capital$461.5MCurrent assets - current liabilities.
Goodwill and intangibles / assets15.4%(Goodwill + intangible assets) / total assets.
Tangible book value$873.7MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover1.49xRevenue / average total assets.
Fixed asset turnover7.71xRevenue / average property, plant and equipment.
Inventory turnover5.71xCost of revenue / average inventory.
Days inventory64 days365 x average inventory / cost of revenue.
Receivables turnover19.8xRevenue / average receivables.
Days sales outstanding18 days365 x average receivables / revenue.
Days payables10 days365 x average accounts payable / cost of revenue.
Cash conversion cycle73 daysDays inventory + days sales outstanding - days payables.
FCF conversion129.5%Free cash flow / net income, when net income is positive.
Capex / operating cash flow18.1%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$23.27Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$295.15Revenue / diluted weighted shares.
FCF per share$30.14Free cash flow / diluted weighted shares.
Operating cash flow per share$36.79Cash from operations / diluted weighted shares.
Book value per share$144.03Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$113.33Tangible book value / shares outstanding.
Cash per share$33.92(Cash + short-term investments) / shares outstanding.
Buybacks / FCF59.6%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$4.29BShare price x shares outstanding.
Enterprise value$4.02BMarket cap + total debt - cash - short-term investments.
P/E23.7xMarket cap / net income. Only when net income is positive.
P/S1.87xMarket cap / revenue.
P/B3.86xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book4.90xMarket cap / tangible book value, when positive.
P/FCF18.3xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF15.0xMarket cap / cash from operations, when positive.
EV/Sales1.75xEnterprise value / revenue.
EV/EBIT18.2xEnterprise value / operating income, when both are positive.
EV/EBITDA16.5xEnterprise value / EBITDA, when both are positive.
EV/FCF17.1xEnterprise value / free cash flow, when both are positive.
FCF yield5.5%Free cash flow / market cap.
Earnings yield4.2%Net income / market cap (the inverse of P/E).
Shareholder yield3.3%(Dividends paid + share buybacks) / market cap.
What was CAVCO INDUSTRIES, INC.'s revenue in fiscal 2026?

CAVCO INDUSTRIES, INC. reported revenue of $2.24B for fiscal 2026, 11.4% higher than the year before.

Was CAVCO INDUSTRIES, INC. profitable in fiscal 2026?

Yes. Net income was $190.6M, a net margin of 8.5%.

How much free cash flow did CAVCO INDUSTRIES, INC. generate in fiscal 2026?

Cash from operations of $267.5M minus capital expenditures of $35.4M left free cash flow of $232.1M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to CAVCO INDUSTRIES, INC.